Stock Price Forecast

April 26, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading MILESTONE SCIENTIFIC INC. chart...

About the Company

We do not have any company description for MILESTONE SCIENTIFIC INC. at the moment.

Exchange

NYSE

$10M

Total Revenue

40

Employees

$42M

Market Capitalization

-4.67

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $MLSS News

Top 4 Health Care Stocks That May Plunge This Month

on MSN ago, source:

As of April 26, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum ...

ImmunityBio Inc. Drug Approved By FDA

3d ago, source: The Post-Journal

A monumental achievement for ImmunityBio, Inc. occurred earlier this week, leaving the door open for potential major benefits ...

Labcorp to acquire Invitae in strategic deal

1d ago, source: Under30CEO on MSN

Invitae Corporation, a leading company in medical genetics, recently confirmed an agreement with Labcorp for the latter’s ...

Peninsula biotech co-founded by Jennifer Doudna lands CRISPR gene-editing pact with Regeneron

3d ago, source:

The big deal between Regeneron and a Peninsula biotech co-founded by Jennifer Doudna is also a small deal. And that’s a huge ...

Cidara Therapeutics: Now Well-Funded To Advance Its Cloudbreak Platform

2d ago, source:

Cidara Therapeutics, Inc. secures funding and focuses on oncology platform after passing rezafungin rights to Mundipharma.

Natera Announces Significant Milestone with 200+ Peer-Reviewed Publications

6d ago, source:

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced that it has passed ...

RVPH: Full Year 2023 Results

3d ago, source: Zacks Small Cap Research on MSN

RVPH READ THE FULL RVPH RESEARCH REPORT 2023 Financial and Operational Results On April 15th, 2024, Reviva Pharmaceutical ...

Global Single-Use Filtration Assemblies Market Revenue to Cross US$ 19.28 Billion Milestone by 2033, Driven by Impressive 18.5% CAGR

11d ago, source: Future Market Insights

The single-use filtration assemblies market is aiming to achieve a significant valuation of US$ 19.28 billion by 2033, ...

Petri Dish: Vertex scales cell manufacturing; German biotech enters Mass.

3d ago, source:

This week saw a German biotech announce its expansion to Greater Boston. Then, Boston’s own Vertex Pharmaceuticals looked ...

Sierra Nevada Wins $13B Contract to Upgrade US Air Force Fleet with New 'Doomsday' Nightwatch Planes

8h ago, source: techtimes

Sierra Nevada Corporation secures $13B contract to upgrade USAF's E-4B "Doomsday" fleet with Survivable Airborne Operations ...

Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP)

2d ago, source:

Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP) Worldwide rights come with $17 million in non-dilutive grant funding ...

Medigene AG reports Financial Results and Business Update for Q1 2024

2d ago, source:

Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...